Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Inventory Average (2019 - 2026)

Sunshine Biopharma filings provide 7 years of Inventory Average readings, the most recent being $13.8 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 30.51% to $13.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.8 million, a 30.51% increase, with the full-year FY2025 number at $12.4 million, up 45.48% from a year prior.
  • Inventory Average hit $13.8 million in Q4 2025 for Sunshine Biopharma, up from $13.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $13.8 million in Q4 2025 to a low of $25215.5 in Q1 2021.
  • Median Inventory Average over the past 5 years was $4.2 million (2023), compared with a mean of $5.3 million.
  • Biggest five-year swings in Inventory Average: skyrocketed 2337.76% in 2023 and later surged 30.51% in 2025.
  • Sunshine Biopharma's Inventory Average stood at $88480.0 in 2021, then skyrocketed by 1911.52% to $1.8 million in 2022, then soared by 188.01% to $5.1 million in 2023, then surged by 105.81% to $10.5 million in 2024, then soared by 30.51% to $13.8 million in 2025.
  • The last three reported values for Inventory Average were $13.8 million (Q4 2025), $13.5 million (Q3 2025), and $12.4 million (Q2 2025) per Business Quant data.